Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Inventory Average (2016 - 2025)

Historic Inventory Average for Ocular Therapeutix (OCUL) over the last 12 years, with Q4 2025 value amounting to $3.5 million.

  • Ocular Therapeutix's Inventory Average rose 2951.33% to $3.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.5 million, marking a year-over-year increase of 2951.33%. This contributed to the annual value of $3.3 million for FY2025, which is 2355.47% up from last year.
  • Per Ocular Therapeutix's latest filing, its Inventory Average stood at $3.5 million for Q4 2025, which was up 2951.33% from $3.3 million recorded in Q3 2025.
  • Ocular Therapeutix's 5-year Inventory Average high stood at $3.5 million for Q4 2025, and its period low was $1.1 million during Q2 2021.
  • Its 5-year average for Inventory Average is $2.1 million, with a median of $2.2 million in 2023.
  • In the last 5 years, Ocular Therapeutix's Inventory Average soared by 280.59% in 2021 and then skyrocketed by 6257.67% in 2023.
  • Ocular Therapeutix's Inventory Average (Quarter) stood at $1.2 million in 2021, then surged by 42.35% to $1.8 million in 2022, then increased by 29.64% to $2.3 million in 2023, then rose by 19.36% to $2.7 million in 2024, then rose by 29.51% to $3.5 million in 2025.
  • Its Inventory Average was $3.5 million in Q4 2025, compared to $3.3 million in Q3 2025 and $3.2 million in Q2 2025.